BIOMAT Database Logo BIOMAT Database Logo

Local control of breast cancer with tumorectomy plus radiotherapy or radiotherapy alone. 1976

N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy

58 cases of breast cancer treated primarily by radiotherapy were evaluated to determine the optimum dose for local control. Of 36 patients with T1 + T2 lesions who had tumorectomy prior to radiotherapy, incomplete excision of tumor was demonstrated on microscopic examination in 18. The minimum tumor dose to the breast was 4,500 rads in 5 weeks. Treatment failed to control local tumor in only 2 (5%) and metastases in 1.26 (72%) remained disease-free for 2 to 9 years. Of the 22 patients with T3 + T4 lesions, treatment failed to control both local tumor and metastases in 12 (54%); in those who received 6,000 rads or less in 6 weeks, treatment failed to control any of these lesions. 4,500-5,500 rads controlled the tumor in 95% of those with NO + N1 disease, compared to only half of those with N2 + N3 tumors.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011867 Radioisotope Teletherapy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. Teleradioisotope Therapy,Teletherapy, Radioisotope,Therapy, Teleradioisotope
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D005260 Female Females

Related Publications

N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
Relation between time-dose and local control of operable breast cancer treated by tumorectomy and radiotherapy or by radical radiotherapy alone.
October 1978, Cancer,
N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
Tumorectomy plus radiotherapy in the management of breast cancer.
December 1985, Tumori,
N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
Local control of operable breast cancer after radiotherapy alone.
January 1990, European journal of cancer (Oxford, England : 1990),
N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
[Conservative treatment of breast cancer by telecobalt alone or associated with tumorectomy or interstitial curietherapy].
November 1971, Journal de radiologie, d'electrologie, et de medecine nucleaire,
N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
[Adjuvant radiotherapy following tumorectomy of breast cancer].
July 1990, Revue medicale de la Suisse romande,
N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
Postoperative radiotherapy for prostate cancer : Morbidity of local-only or local-plus-pelvic radiotherapy.
January 2018, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
Adriamycin plus vincristine alone or with dibromodulcitol or ICRF-159 in metastatic breast cancer.
January 1981, Cancer clinical trials,
N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
[Tumorectomy. Radiotherapy].
November 1967, Journal de radiologie, d'electrologie, et de medecine nucleaire,
N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
[Tumorectomy in breast cancer].
June 1983, Medicina clinica,
N A Ghossein, and P Stacey, and R T Alpert, and P J Ager, and V Krishnaswamy
Tumorectomy plus tamoxifen for the treatment of breast cancer in the elderly.
December 1993, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Copied contents to your clipboard!